Navigation Links
PharmaDirections Celebrates 10 Years of Success for Their Virtual Biotech and Pharmaceutical Clients
Date:4/16/2013

Cary, NC (PRWEB) April 16, 2013

PharmaDirections is celebrating 10 years of providing pharmaceutical consulting and project management services to biotech and pharmaceutical company clients. With specialized expertise in preclinical studies, biopharmaceutics, pharmacokinetics, formulation development and regulatory affairs, PharmaDirections has been able to provide clients with resources to fill in gaps between success in the laboratory and proof of concept in the clinic.

PharmaDirections specializes in getting the innovations of small and virtual startup companies from concept to the clinic and beyond, to proof of concept and partnering. The company utilizes an extensive network of seasoned experts and service providers in CMC, preclinical, and regulatory to provide a seamless path through the labyrinth that is pharmaceutical development.

Company President Richard Soltero, Ph.D. founded PharmaDirections in 2003 to fill a unique need of the very small, often virtual, biopharmaceutical companies that were quickly springing out of universities and medical centers. While contract development services were well developed by that time, few vendors could provide the management and oversight needed to put all the pieces together. Utilizing connections developed during his 30+ years in the pharmaceutical industry, Dr. Soltero pulled together a network of experts in various aspects of drug development to provide the virtual management teams these small companies needed to achieve their goals.

Since the company's inception, PharmaDirections has helped over 150 clients with their research programs by providing preclinical, chemistry, formulation, and regulatory affairs expertise. PharmaDirections operates with a core staff spearheaded by Dr. Soltero, and three Principals, Drs. Michelle Higgin, Bruce Rehlaender and Sara McKenzie. They oversee the work of nearly 60 associates who work closely with over 100 contract research organizations that conduct the studies needed to help move their clients’ drugs from lead identification to Phase two clinical studies. Using PharmaDirections allows clients to keep their own companies lean while still having access to the world-class resources and expertise normally found only in large pharmaceutical companies.

About PharmaDirections

PharmaDirections provides pharmaceutical consulting and project management services with special expertise in preclinical development, formulation development and CMC, and regulatory affairs. PharmaDirections is structured to help biotech and pharmaceutical companies navigate from preclinical drug development to the clinic faster and with higher quality than traditional outsourcing options. Our Project Leaders design, direct and manage preclinical, CMC and regulatory affairs projects with an emphasis on science and a focus on staying within budget and delivering on time.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10629652.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmaDirections Succeeds Through its Client’s Successes: Cortendo Receives Positive Orphan Drug Opinion from EMA for NormoCort for Cushing’s Disease
2. PharmaDirections Announces Appointment of Dr. Bruce Rehlaender as Principal, Formulation Development
3. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
4. Chicago Celebrates First Informatics Week, Co-Chaired by Intelligent Medical Objects and Northwestern University
5. OBNs 2012 Annual Awards Dinner Celebrates UK Bioscience Success Stories
6. Christmas Special: My Cleaning Products Celebrates Holiday With a Molderizer and Safe Shield Markdown for its Clients
7. Dallas-Fort Worth Fertility Associates Celebrates First Birth in North Texas from Advanced Trophectoderm Biopsy Screening Technology
8. Identigene Turns 20! Identigene DNA Laboratory Celebrates 20 Year Anniversary
9. How Hot or Cold is it? H-B Instrument Puts Celebrates 110 Years of Manufacturing High-Quality Thermometers and More
10. Amphora Research Systems Celebrates its Tenth Birthday
11. Stoneville Cotton Seed from Bayer CropScience Celebrates 90 Years of Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell ... RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
Breaking Biology Technology:
(Date:11/17/2016)... CITY OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it ... about using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer ... ... ... Setting ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):